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Human sparganosis is a foodborne zoonosis endemic in 
Asia. We report a series of 9 histologically confirmed hu-
man sparganosis cases in Hong Kong, China. All parasites 
were retrospectively identified as Spirometra erinaceieuro-
paei. Skin and soft tissue swelling was the most common 
symptom, followed by central nervous system lesions.
Sparganosis is a parasitic zoonosis endemic in Asia, Eu-rope, and North America. Diphyllobothroid tapeworm 
under the genus Spirometra is the causative agent. Humans 
can be infected through the consumption of contaminated 
water or meat from intermediate hosts or through topical 
application of raw, contaminated poultices to eyes and open 
wounds. After entry into humans, the plerocercoid larvae 
(spargana) migrate to different anatomic locations, where 
they cause space-occupying lesions as they develop into 
adults. The sites spargana migrate to include skin and soft 
tissues, muscles, visceral organs, and the central nervous 
system. Clinical symptoms range from asymptomatic/mild 
(e.g., subcutaneous swelling) to severe (e.g., seizure and 
hemiparesis) depending on the site and size of lesions (1).
Sparganosis is an emerging zoonotic disease and 
public health challenge in China, potentially because of 
the practice of consuming wild frog meat, which is a deli-
cacy in the southern Guangdong province. According to a 
2009 survey, >25% of the local wild frogs were infected 
with spargana (2). Most cases of human sparganosis have 
been found in Asia, with the highest cumulative number in 
China (online Technical Appendix Table, https://wwwnc.
cdc.gov/EID/article/23/4/16-0791-Techapp1.pdf) (3). In 
Hong Kong, the earliest known cases of sparganosis were 
2 subcutaneous infections reported in 1962 (4), and cases 
afterward have been sporadic. With advances in molecular 
sequencing, the identification of sparganum larvae isolated 
from humans was made possible (5,6). In this study, we 
performed molecular sequencing on archived histologic 
specimens to delineate the parasites down to species level.
The Study
Cases of human sparganosis were identified by searching 
the clinical, parasitologic, and histopathologic records in 
the Queen Elizabeth Hospital and the Pamela Youde Neth-
ersole Eastern Hospital in Hong Kong. Archived histo-
pathology specimens showing parasites compatible with 
plerocercoids were retrieved for further molecular testing. 
We made 10–15 (depending on the amount of tissue avail-
able) 4-µm sections from each paraffin block; the sections 
were deparaffinized and suspended in sterile, normal saline. 
Genomic DNA was extracted from formalin-fixed paraf-
fin-embedded tissue by using a DNA minikit (QIAGEN, 
Hilden, Germany) according to the manufacturer’s instruc-
tions. The DNA was eluted in 60 µL of elution buffer and 
used as template for PCR.
Primer sequences used in this study were cox1-F 
5′-CGGCTTTTTTTGATCCTTTGGGTGG-3′, cox1-
R 5′-GTATCATATGAACAACCTAATTTAC-3′, 
28S-F 5′-CACCGAAGC CTGCGGTA-3′, and 28S-R 
5′-GAAGGTCGACCTGGTGAA-3′, which targeted spe-
cifically to the cox1 and 28S rRNA genes of S. erinaceieu-
ropaei respectively (7). The later primers were designed in-
house by multiple alignments of different parasite species. 
The PCR mixture (25 µL) contained DNA, PCR buffer (10 
mmol/L Tris-HCl [pH 8.3], 50 mmol/L KCl, 3 mmol/L 
MgCl2, and 0.01% gelatin), and 200 mmol/L each deoxy-
nucleoside triphosphate (dNTP) and 1.0 U Taq polymerase 
(Applied Biosystems, Foster City, CA, USA). The mix-
tures were amplified in 60 cycles of 94°C for 1 min, 55°C 
for 1 min, and 72°C for 1 min with a final extension at 72°C 
for 10 min in an automated thermal cycler (Applied Biosys-
tems). Standard precautions were taken to avoid PCR con-
tamination, and no false-positive results were observed in 
negative controls. PCR products were gel purified by using 
the QIAquick gel extraction kit (QIAGEN). Both strands of 
the PCR products were sequenced twice with an ABI Prism 
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3700 DNA analyzer (Applied Biosystems). Sequences of 
the PCR products were compared with known sequences 
by BLAST analysis (https://blast.ncbi.nlm.nih.gov).
We constructed a phylogenetic tree using the neighbor-
joining method with Kimura’s 2-parameter correction with 
ClustalX 1.83 (http://www.clustal.org). We included in the 
analysis the 252 bps and 211 bps of the amplicon from the 
cox1 gene (GenBank accession nos. KU760072–81) and 
the 28S rRNA gene (accession nos. KX831668–77) of S. 
erinaceieuropaei, respectively, detected in positive sam-
ples. Strongyloides stercoralis was used as the outgroup in 
these analyses.
Seven patients with human sparganosis were identified 
in Queen Elizabeth Hospital, and 2 patients were identified 
in the Pamela Youde Nethersole Eastern Hospital. All diag-
noses were made from 1999 to 2015 (Table). Eight patients 
were Chinese; 1 was Filipino, and 4 were male. Patient age 
at diagnosis was 29–73 (median 49) years. Three patients 
displayed neurologic symptoms, such as numbness, weak-
ness, or memory impairment, and the other 6 displayed skin 
and soft tissue involvement. All had progressively enlarging 
or migratory skin nodules (Table). Additional information 
on clinical history, histopathology, and magnetic resonance 
brain imaging of representative cases was collected (online 
Technical Appendix). 
Nine patients had archived histopathologic specimens 
available for molecular testing. Parasite identification was 
achieved in all 9 specimens, and they showed 99%–100% and 
100% identity with the cox1 and 28S rRNA gene sequences 
of S. erinaceieuropaei, respectively (Figure, panels A and B).
Conclusions
This study demonstrates that human sparganosis appeared 
sporadically in Hong Kong. The most common signs of dis-
ease were skin and soft tissue nodules followed by intracra-
nial lesions. By molecular sequencing, the tested parasites 
were S. erinaceieuropaei. We were unable to pinpoint the 
source of infection in most patients; the incubation period 
can last as long as several months, and early stages of the 
disease are usually asymptomatic (8). Patients might have 
difficulty recalling specific high-risk exposures. In most in-
dustrialized countries, the practice of applying raw frog or 
snake poultices to open wounds is regarded as unhygienic 
and becoming obsolete, yet consumption of undercooked 
frog meat or, less commonly, ingestion of raw snake bile 
for medicinal purposes is still practiced in Hong Kong. 
Another possible route of transmission could have been 
drinking water contaminated with Spirometra procercoids.
Subcutaneous sparganosis is the most commonly rec-
ognized form of the disease. Because sparganosis is rare, it 
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Table. Characteristics of cases of human sparganosis, Hong Kong, 1999–2015* 
Pt 
no. Year 
Age, 
y/sex  Ethnicity 
Probable 
place/mode of 
infection 
Location of 
lesion 
Size of worm or 
lesion, cm Clinical features 
PEC,  109/L  
(% total WBC 
count) 
1 1999 67/F Chinese Unk/Unk Right breast 0.15 × 0.1 × 0.7, 
0.15 × 0.1 × 0.7, 
0.1 × 0.5 × 0.5 
(lesions excised) 
Right breast mass NR 
2 2000 46/M Chinese Unk/Unk NR 0.15 (worm length) NR NR 
3 2002 29/F Chinese Unk/Unk Epigastrium of 
abdominal 
wall  
4 × 2.5 × 2 (lesion 
excised) 
NR NR 
4 2003 63/F Chinese Unk/Unk Left thigh 0.6 (maximum 
dimension of lesion 
excised) 
Progressive enlarging mass 
for 2 years 
NR 
5 2004  44/M Chinese Unk/Unk Right thigh 1.5 × 1.5 (lesion); 
0.27 × 0.2 × 0.5 
(worm) 
Right thigh nodule for 6 
months 
NR 
2014  55/M Unk/Unk Right thigh 
and suspected 
left frontal lobe 
1.6 × 1.3 × 1.4 
(lesion) 
Recurrent right thigh nodule; 
suspicious 2 × 5 × 5 mm 
T2W/FLAIR hyperintensity 
with contrast enhancement 
in left frontal white matter 
0.22 (3.7) 
6 2005 43/F Chinese Unk/Unk Left breast 0.21 (lesion 
excised) 
Progressive enlarging left 
breast mass 
0.1 (0.7) 
7 2011 58/M Chinese China/ingestion 
of frogs and 
snakes 
Left chest wall 3 × 2.5 × 1 (lesion) Left chest wall mass for 3 
years 
0.21 (2.5) 
8 2013 49/F Filipino Unk/Unk Left parietal 
lobe 
0.17 × 0.12 × 0.23 
(lesion) 
Right-sided numbness and 
weakness for 2 days 
0.1 (1.1) 
9 2015 73/M Chinese China/ingestion 
of frogs 
Left thigh 0.5 × 0.5 × 0.1 
(lesion excised) 
Progressive enlarging left 
inner thigh mass for 1 year 
0.21 (4.2) 
*All worms were identified as Spirometra erinaceieuropaei. NR, not recorded; PEC, peripheral eosinophil count; Pt, patient; T2W/FLAIR, T2-weighted/fluid 
attenuation inversion recovery; Unk, unknown; WBC, white blood cell. 
 
Human Sparganosis in Hong Kong
is seldom considered during an initial patient assessment, 
although a migratory nodule might raise the suspicion for 
a helminthic etiology. Diagnosis of sparganosis needs to 
be confirmed, normally by studying the excised lesions. 
Even though serologic tests for sparganosis have been 
described, these assays are not generally available and their 
performance requires more evaluation (9–13). In contrast, 
the presence of tunnel sign, conglomerated rings, bead-
shaped enhancements, or images of parasites of various life 
stages by computerized tomography or magnetic resonance 
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Figure. Phylogenetic analysis of cox1 and 28S rRNA genes of archived formalin-fixed paraffin-embedded tissues obtained from human 
sparganosis cases, Hong Kong, 1999–2015. A) A 252-bp sequence from the cox1 gene (GenBank accession nos. KU760072–81) was 
included for each isolate. B) A 211-bp sequence from the 28S rRNA gene (accession nos. KX831668–77) was included for each isolate. 
Trees were constructed by using the neighbor-joining method and rooted with the corresponding sequence in Strongyloides stercoralis 
(accession nos. AB526297.1 and U39489.1 for cox1 and 28S rRNA genes, respectively). The bootstrap values are shown for nodes that 
appeared in >70% of the 1,000 replicates. The species used for comparison and their GenBank accession numbers are given in the 
tree. Scale bars indicate estimated number of substitutions per 50 bases.
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imaging are suggestive of sparganosis (14). Histopatholog-
ic diagnosis of parasitic infections remains a challenge to 
pathologists in countries where sparganosis is not endemic. 
Recognizing the different phyla and classes of parasites 
(i.e., nematodes, cestodes, and trematodes) histologically 
is usually simple. However, specific identification of the 
genus and species requires substantial expertise in parasite 
pathology and morphology. Identification of rare parasites 
is sometimes impossible because of the lack of detailed 
morphologic descriptions in the literature. Under such cir-
cumstances, molecular studies provide useful information 
for species identification (15). Nevertheless, it is not infal-
lible, especially for rare parasites, because precise species 
identification depends on gene sequence availability and 
data accuracy.
Although the parasitic drug praziquantel has wide cov-
erage against several cestodes and trematodes, its efficacy 
in the treatment of sparganosis remains uncertain. Surgical 
intervention for complete worm removal should be used 
whenever feasible.
This study had limitations. We only included infor-
mation on patients from 2 of the 7 geographic clusters 
of public hospitals in Hong Kong, and those with as-
ymptomatic subcutaneous lesions most likely did not 
seek medical attention. The reported number is certainly 
an underestimate. 
Given that human sparganosis is an emerging zoo-
notic parasitic infection, clinicians may consider it in the 
differential diagnosis for mass lesions with undetermined 
etiology. Education of the general public about food safety, 
including avoiding the consumption of untreated water and 
undercooked frog and snake meat, is needed.
Acknowledgments
We thank Sherman Lo for providing magnetic resonance  
imaging brain scans.
Dr. Tang is the associate consultant of the Division of Infectious 
Diseases in the Department of Medicine at Queen Elizabeth 
Hospital. His research interests are emerging infectious diseases, 
infections in immunocompromised hosts, infectious disease 
epidemiology, and global health.
References
  1. Liu Q, Li MW, Wang ZD, Zhao GH, Zhu XQ. Human sparganosis, 
a neglected food borne zoonosis. Lancet Infect Dis. 2015;15:1226–
35. http://dx.doi.org/10.1016/S1473-3099(15)00133-4
  2. Li MW, Lin HY, Xie WT, Gao MJ, Huang ZW, Wu JP, et al. 
Enzootic sparganosis in Guangdong, People’s Republic of China. 
Emerg Infect Dis. 2009;15:1317–8. http://dx.doi.org/10.3201/
eid1508.090099
  3. Zhang X, Cui J, Liu LN, Jiang P, Wang H, Qi X, et al.  
Genetic structure analysis of Spirometra erinaceieuropaei isolates 
from central and southern China. PLoS One. 2015;10:e0119295. 
http://dx.doi.org/10.1371/journal.pone.0119295
  4. Huang CT, Kirk R. Human sparganosis in Hong Kong. J Trop Med 
Hyg. 1962;65:133–8.
  5. Boonyasiri A, Cheunsuchon P, Suputtamongkol Y, Yamasaki H, 
Sanpool O, Maleewong W, et al. Nine human sparganosis cases in 
Thailand with molecular identification of causative parasite species. 
Am J Trop Med Hyg. 2014;91:389–93. http://dx.doi.org/10.4269/
ajtmh.14-0178
  6. Jeon HK, Park H, Lee D, Choe S, Kim KH, Huh S, et al.  
Human Infections with Spirometra decipiens plerocercoids  
identified by morphologic and genetic analyses in Korea.  
Korean J Parasitol. 2015;53:299–305. http://dx.doi.org/10.3347/
kjp.2015.53.3.299
  7. Koonmee S, Intapan PM, Yamasaki H, Sugiyama H, Muto M, 
Kuramochi T, et al. Molecular identification of a causative parasite 
species using formalin-fixed paraffin embedded (FFPE) tissues  
of a complicated human pulmonary sparganosis case without  
decisive clinical diagnosis. Parasitol Int. 2011;60:460–4.  
http://dx.doi.org/10.1016/j.parint.2011.07.018
  8. Tappe D, Berger L, Haeupler A, Muntau B, Racz P, Harder Y,  
et al. Case report: molecular diagnosis of subcutaneous  
Spirometra erinaceieuropaei sparganosis in a Japanese immigrant. 
Am J Trop Med Hyg. 2013;88:198–202. http://dx.doi.org/10.4269/
ajtmh.2012.12-0406
  9. Yeo IS, Yong TS, Im K. Serodiagnosis of human sparganosis by 
a monoclonal antibody-based competition ELISA. Yonsei Med J. 
1994;35:43–8. http://dx.doi.org/10.3349/ymj.1994.35.1.43
10. Cui J, Li N, Wang ZQ, Jiang P, Lin XM. Serodiagnosis of  
experimental Sparganum infections of mice and human  
sparganosis by ELISA using ES antigens of Spirometra mansoni  
spargana. Parasitol Res. 2011;108:1551–6. http://dx.doi.org/ 
10.1007/s00436-010-2206-2
11. Rahman SMM, Kim JH, Hong ST, Choi MH. Diagnostic efficacy 
of a recombinant cysteine protease of Spirometra erinacei larvae 
for serodiagnosis of sparganosis. Korean J Parasitol. 2014;52:41–6. 
http://dx.doi.org/10.3347/kjp.2014.52.1.41
12. Liu LN, Zhang X, Jiang P, Liu RD, Zhou J, He RZ, et al.  
Serodiagnosis of sparganosis by ELISA using recombinant  
cysteine protease of Spirometra erinaceieuropaei spargana.  
Parasitol Res. 2015;114:753–7. http://dx.doi.org/10.1007/ 
s00436-014-4270-5
13. Liu LN, Wang ZQ, Zhang X, Jiang P, Qi X, Liu RD, et al.  
Characterization of Spirometra erinaceieuropaei plerocercoid 
cysteine protease and potential application for serodiagnosis of 
sparganosis. PLoS Negl Trop Dis. 2015;9:e0003807.  
http://dx.doi.org/10.1371/journal.pntd.0003807
14. Lo Presti A, Aguirre DT, De Andrés P, Daoud L, Fortes J, Muñiz J. 
Cerebral sparganosis: case report and review of the European cases. 
Acta Neurochir (Wien). 2015;157:1339–43, discussion 1343.  
http://dx.doi.org/10.1007/s00701-015-2466-9
15. Wong SSY, Fung KSC, Chau S, Poon RWS, Wong SCY,  
Yuen KY. Molecular diagnosis in clinical parasitology: when  
and why? Exp Biol Med (Maywood). 2014;239:1443–60.  
http://dx.doi.org/10.1177/1535370214523880
Address for correspondence: Tommy H.C. Tang, Division of Infectious 
Diseases, Department of Medicine, Queen Elizabeth Hospital, 30 
Gascoigne Rd, Hong Kong, China; email: thc061@gmail.com
668 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No.4, April 2017
